Weiss Multi Strategy Advisers LLC Insmed Inc Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$23.42 - $31.74 $744,053 - $1.01 Million
31,770 Added 83.1%
70,000 $2.17 Million
Q3 2023

Nov 14, 2023
SELL
$19.86 - $26.93 $569,445 - $772,163
-28,673 Reduced 42.86%
38,230 $965,000
Q2 2023

Aug 14, 2023
SELL
$16.44 - $21.1 $1 Million - $1.28 Million
-60,862 Reduced 47.64%
66,903 $1.41 Million
Q1 2023

May 15, 2023
SELL
$16.26 - $21.73 $238,485 - $318,713
-14,667 Reduced 10.3%
127,765 $2.18 Million
Q4 2022

Feb 14, 2023
BUY
$16.98 - $23.15 $888,393 - $1.21 Million
52,320 Added 58.06%
142,432 $2.85 Million
Q3 2022

Nov 14, 2022
SELL
$20.88 - $28.21 $208,800 - $282,100
-10,000 Reduced 9.99%
90,112 $1.94 Million
Q2 2022

Aug 15, 2022
BUY
$17.07 - $25.71 $838,341 - $1.26 Million
49,112 Added 96.3%
100,112 $1.97 Million
Q1 2022

May 16, 2022
BUY
$20.42 - $28.13 $109,349 - $150,636
5,355 Added 11.73%
51,000 $1.2 Million
Q4 2021

Feb 14, 2022
BUY
$25.89 - $33.45 $42,589 - $55,025
1,645 Added 3.74%
45,645 $1.24 Million
Q3 2021

Nov 15, 2021
BUY
$22.46 - $29.47 $382,134 - $501,402
17,014 Added 63.05%
44,000 $1.21 Million
Q2 2021

Aug 16, 2021
BUY
$24.17 - $36.01 $93,658 - $139,538
3,875 Added 16.77%
26,986 $768,000
Q1 2021

May 14, 2021
SELL
$32.28 - $44.3 $30,052 - $41,243
-931 Reduced 3.87%
23,111 $787,000
Q4 2020

Feb 16, 2021
SELL
$31.45 - $40.54 $661,770 - $853,042
-21,042 Reduced 46.67%
24,042 $800,000
Q3 2020

Nov 16, 2020
SELL
$26.0 - $34.5 $627,692 - $832,899
-24,142 Reduced 34.87%
45,084 $1.45 Million
Q2 2020

Aug 14, 2020
BUY
$14.11 - $29.42 $214,838 - $447,948
15,226 Added 28.2%
69,226 $1.91 Million
Q1 2020

May 15, 2020
BUY
$13.63 - $33.98 $122,670 - $305,820
9,000 Added 20.0%
54,000 $866,000
Q4 2019

Feb 14, 2020
BUY
$16.12 - $24.98 $96,720 - $149,880
6,000 Added 15.38%
45,000 $1.08 Million
Q3 2019

Nov 14, 2019
BUY
$15.49 - $25.78 $139,410 - $232,020
9,000 Added 30.0%
39,000 $688,000
Q2 2019

Aug 14, 2019
SELL
$23.0 - $32.19 $276,000 - $386,280
-12,000 Reduced 28.57%
30,000 $768,000
Q1 2019

May 15, 2019
BUY
$13.91 - $31.15 $445,120 - $996,800
32,000 Added 320.0%
42,000 $1.22 Million
Q4 2018

Feb 14, 2019
SELL
$11.6 - $18.7 $232,000 - $374,000
-20,000 Reduced 66.67%
10,000 $131,000
Q3 2018

Nov 14, 2018
SELL
$18.95 - $28.08 $909,600 - $1.35 Million
-48,000 Reduced 61.54%
30,000 $607,000
Q2 2018

Aug 14, 2018
BUY
$20.0 - $29.72 $160,000 - $237,760
8,000 Added 11.43%
78,000 $1.85 Million
Q1 2018

May 15, 2018
BUY
$21.69 - $32.99 $433,800 - $659,800
20,000 Added 40.0%
70,000 $1.58 Million
Q4 2017

Feb 14, 2018
SELL
$26.43 - $31.78 $660,750 - $794,500
-25,000 Reduced 33.33%
50,000 $1.56 Million
Q3 2017

Nov 14, 2017
BUY
$11.61 - $31.21 $870,750 - $2.34 Million
75,000
75,000 $2.34 Million

Others Institutions Holding INSM

# of Institutions
465
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email